Ultrasound Evaluation of Preventive Measures for Postoperative Lung Atelectasis After Surgery (LUS/PEEP/RM)

December 19, 2025 updated by: Hamed Mohamed Wally Allah, Al-Azhar University

Ultrasound Evaluation of Different Preventive Measures of Post Operative Lung Atelectasis After Upper Abdominal Surgeries: Ventilation and Fluid Measures

the aim of this prospective randomized blinded clinical study will be to assess the ultrasound evaluation of different preventive measures of post operative lung atelectasis in abdominal surgeries; these measures include ventilation and fluid measures

Study Overview

Detailed Description

ultrasound evaluation for application of different preventive measures of post operative lung atelectasis, including positive end-expiratory pressure, lung recruitment maneuvers, and restrictive fluid management.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Asyut, Egypt
        • Al-Azhar University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • ASA physical status I or II, of either gender.
  • BMI < 40
  • Age 30-60 years
  • scheduled for elective abdominal surgeries

Exclusion Criteria:

  • Patient refusal
  • American Society of Anesthesiologists (ASA) physical status classification system more than II
  • BMI > 40 .
  • Psychiatric disorders
  • History of chest disorders such as asthma and obstructive pulmonary disease (COPD).
  • History of Previous Thoracic Procedures.
  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group I: PEEP
Patients will be ventilated with PEEP of 8 cm H2O and fluid management: 500 ml of Ringer's lactate in the recovery room before surgery and Ringer's lactate at a rate of 4 mL/kg/hour from the beginning to the end of the surgery.
Patients will be ventilated with PEEP of 8 cm H2O and fluid management: 500 ml of Ringer's lactate in the recovery room before surgery and Ringer's lactate at a rate of 4 mL/kg/hour from the beginning to the end of the surgery.
Experimental: Group II: PEEP/RM
Patients will be ventilated with PEEP of 8 cm H2O, and then RM (30 cm H2O for 30 s) will be applied immediately after the second LUS examination and repeated every 30 minutes till emergence and fluid management: 500 ml of Ringer's lactate in recovery room before surgery and Ringer's lactate at a rate of 4 mL/kg/hour from the beginning to the end of the surgery
Patients will be ventilated with PEEP of 8 cm H2O, and then RM (30 cm H2O for 30 s) will be applied immediately after the second LUS examination and repeated every 30 minutes till emergence and fluid management: 500 ml of Ringer's lactate in recovery room before surgery and Ringer's lactate at a rate of 4 mL/kg/hour from the beginning to the end of the surgery
Experimental: Group III: PEEP/RM/RF
Patients will be ventilated with PEEP of 8 cm H2O, and then RM (30 cm H2O for 30 s) will be applied immediately after the second LUS examination and repeated every 30 minutes till emergence and restrictive fluid management (RF). Ringer's lactate at a rate of 3 mL/kg/hour from the beginning to the end of the surgery
Patients will be ventilated with PEEP of 8 cm H2O, and then RM (30 cm H2O for 30 s) will be applied immediately after the second LUS examination and repeated every 30 minutes till emergence and restrictive fluid management (RF). Ringer's lactate at a rate of 3 mL/kg/hour from the beginning to the end of the surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lung ultrasound assessment of postoperative pulmonary atelectasis at the end of surgery
Time Frame: at the end of surgery before emergence from GA.

Lung ultrasound assessment of postoperative pulmonary atelectasis at the end of surgery.

The Lung Ultrasound Score (LUS): the key points based on ultrasound findings:

I. 0 points: (N) Normal aeration (presence of lung sliding with A-lines or <2 separate B-lines).

II. 1 point: (B1) Moderate loss of lung aeration (≥3 well-defined B lines). III. 2 points: (B2) Severe loss of lung aeration (coalescing B-lines). IV. 3 points: (C) Complete loss of lung aeration (pulmonary consolidations). Total Score: points will be distributed according to the worst ultrasound pattern observed: N = 0, B1 lines = 1, B2 lines = 2, C = 3. The LUS score ranging between 0 and 36 was calculated as the sum of points.

at the end of surgery before emergence from GA.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lung ultrasound assessment
Time Frame: before induction of general anesthesia
Lung ultrasound assessment of atelectasis
before induction of general anesthesia
Lung ultrasound assessment
Time Frame: 5 minutes post induction of general anesthesia
Lung ultrasound assessment of atelectasis
5 minutes post induction of general anesthesia
Lung ultrasound assessment
Time Frame: 15 minutes after patients arrive to PACU
Lung ultrasound assessment of atelectasis
15 minutes after patients arrive to PACU
Lung ultrasound assessment
Time Frame: 60 minutes after patients arrive to PACU
Lung ultrasound assessment of atelectasis
60 minutes after patients arrive to PACU
arterial blood gases
Time Frame: 5 minutes post induction of general anesthesia
Pao2, spo2, paco2, pao2/fio2
5 minutes post induction of general anesthesia
arterial blood gases
Time Frame: before emergence from general anesthesia
Pao2, spo2, paco2, pao2/fio2
before emergence from general anesthesia
arterial blood gases
Time Frame: 15 minutes after patients arrive to PACU
Pao2, spo2, paco2, pao2/fio2
15 minutes after patients arrive to PACU

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hamed M Wally Allah, Al-Azhar University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 8, 2024

Primary Completion (Actual)

December 19, 2025

Study Completion (Actual)

December 19, 2025

Study Registration Dates

First Submitted

October 20, 2024

First Submitted That Met QC Criteria

October 21, 2024

First Posted (Actual)

October 23, 2024

Study Record Updates

Last Update Posted (Actual)

December 26, 2025

Last Update Submitted That Met QC Criteria

December 19, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pulmonary Atelectasis, Postoperative

Clinical Trials on PEEP

Subscribe